“…Owing to their unique advantages including well-defined morphology, uniform size, controllable structure, super high specific pore volume, tunable pore size, easily modified surface, high drug-loading capacity, and excellent biocompatibility, mesoporous silica nanoparticles (MSNs) have attracted increasing interest in biomedical applications in the recent decades, especially in controlled drug delivery system (Berger et al, 2016;Chen et al, 2013a;Chen et al, 2014;Chen et al, 2013b;Chin et al, 2014;Ge et al, 2015;Jia et al, 2015;Kim et al, 2015;Knežević et al, 2013;Li et al, 2011;Mamaeva et al, 2013;Niu et al, 2014;Tang and Cheng, 2013;Tao, 2014;von Haartman et al, 2013;. However, the simplex structure of MSNs is barely able to meet the demands of drug release in complicated in vivo environment.…”